About Das Oncocare
Das Oncocare is a Healthcare company. Accessible cancer drugs and OTC health products are provided by Das Oncocare. Its Indian entity Das Oncocare Private Limited reported revenue of ₹12 Lakh. Das Oncocare offers products and services including Cancer Drugs and OTC Sprays. Its focus areas include Pharmaceuticals, Oncology, Cancer Treatments and Consumer Health.
Company details
Das Oncocare is recognized for making the latest cancer drugs and medicines accessible and affordable across various regions. Quality products, including OTC sprays for pain relief and wound care, are offered to meet essential health needs. Operations are registered in the Caribbean, Central America, and the Indian subcontinent, with a commitment to delivering effective therapies. The company emphasizes adherence to high standards in treatment trust, supported by its founders expertise in medicine. This focus ensures life-altering support when it is most needed.
- SectorsHealthcare
- Email••••••••
- Social LinkedIn YouTube
- Legal Name Das Oncocare Pvt. Ltd
- Date of Incorporation 12 Sep, 2018
- Jurisdiction Goregaon E Mumbai, Maharashtra, India
- Indian entity revenue₹12 Lakh
FY 2022 · +11% YoY
- Indian entity net loss-₹32.4 Lakh
FY 2022 · -270% margin
- Indian entity EBITDA-₹32.3 Lakh
FY 2022 · -269% margin
Associated legal entities of Das Oncocare
Das Oncocare operates through Das Oncocare Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Das Oncocare Private Limited CIN U74999MH2018PTC313929 | Active | 12 Sep 2018 | Mumbai, Maharashtra | ₹0.1 Cr | 4 | View details |
Products & Services of Das Oncocare
Das Oncocare offers a comprehensive portfolio of products and services, including Cancer Drugs and OTC Sprays.
Latest cancer drugs and medicines are made accessible and affordable to support treatment needs.
Sprays for sanitizing, pain relief, and wound care are provided to address everyday health concerns.
Apps and channels of Das Oncocare
its YouTube channel Das Oncocare Pvt Ltd has 0026 subscribers.
Board of directors of Das Oncocare Private Limited (Das Oncocare)
Das Oncocare Private Limited is the primary company behind Das Oncocare. The board of Das Oncocare Private Limited currently have 4 directors; the longest-serving is Bandita Saisudha Patro, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bandita Saisudha Patro DIN 02775635 | Director | 12 Sep 2018 | 8 yrs 1 mo | Das Oncocare Private Limited |
| Kiran Das DIN 08222902 | Director | 12 Sep 2018 | 8 yrs 1 mo | Das Oncocare Private Limited |
| Jasmine Das DIN 08222943 | Director | 12 Sep 2018 | 8 yrs 1 mo | Das Oncocare Private Limited |
| Netajee Patro DIN 03166011 | Director | 22 Jul 2022 | 4 yrs 3 mo | Das Oncocare Private Limited |
Financials of Das Oncocare
Figures of Das Oncocare Private Limited, the primary company behind Das Oncocare, for FY 2022. Revenue was ₹12 Lakh (+11% year on year). Net loss was -₹32.4 Lakh (-270% margin). EBITDA was -₹32.3 Lakh (-269% margin). Revenue has grown at a compounded annual rate of +457% over three years.
- ₹12 LakhRevenue · FY 2022 · +11% YoY
- -₹32.4 LakhNet loss · -270% margin
- -₹32.3 LakhEBITDA · -269% margin
- ₹10 LakhPaid-up capital
- +457%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Das Oncocare Private Limited are on its company page.
Detailed financial statements for Das Oncocare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Das Oncocare
The primary company behind Das Oncocare, Das Oncocare Private Limited, reported revenue of ₹12 Lakh for FY 2022, up 11% year on year.
Das Oncocare is recognized for making the latest cancer drugs and medicines accessible and affordable across various regions. Quality products, including OTC sprays for pain relief and wound care, are offered to meet essential health needs. Operations are registered in the Caribbean, Central America, and the Indian subcontinent, with a commitment to delivering effective therapies. The company emphasizes adherence to high standards in treatment trust, supported by its founders expertise in medicine. This focus ensures life-altering support when it is most needed.
Das Oncocare offers Cancer Drugs and OTC Sprays.
Das Oncocare operates through Das Oncocare Private Limited.
The legal entities of Das Oncocare currently have 4 directors, including Bandita Saisudha Patro, Kiran Das, Jasmine Das and others.